Company Dossiers

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for rare diseases. The company's lead product candidate is Deramiocel (CAP-1002), an investig…

CapsoVision, Inc. is a commercial-stage medical technology company specializing in the development of advanced imaging and artificial intelligence (AI) enabled capsule endoscopy solutions designed to identify abnormalities of the gastrointestinal (GI) tract. …

Capstone Holding Corp. (NASDAQ: CAPS), formerly known as Capstone Therapeutics Corp., is a national, technology-enabled building products distribution and installation platform. Headquartered in Alsip, Illinois, the company operates primarily in the wholesale…

CarGurus, Inc. operates a leading multinational online automotive marketplace connecting vehicle buyers and dealers across the United States, the United Kingdom, and Canada. The company leverages a proprietary, data-driven platform to provide transparency in …

CarParts.com, Inc. (NASDAQ: PRTS) is a technology-led e-commerce retailer specializing in aftermarket automotive parts and accessories. Operating for over 30 years, the company serves over 2.5 million unique customers annually through its flagship website (Ca…

Cardiff Oncology, Inc. (Nasdaq: CRDF) is a clinical-stage biotechnology company focused on developing novel cancer therapies by leveraging Polo-like Kinase 1 (PLK1) inhibition. The company's lead asset is onvansertib, a highly specific, oral PLK1 inhibitor de…

Cardinal Health, Inc. (NYSE: CAH) is a leading global healthcare services and products company that serves as a critical link in the healthcare supply chain. The company operates primarily through two major segments: Pharmaceutical and Specialty Solutions, wh…

Cardinal Infrastructure Group Inc. (NASDAQ: CDNL), formerly known as Civil Infrastructure Group Inc., is a Raleigh, North Carolina-based civil contracting company. Founded in 2013 by CEO Jeremy Spivey, the company rebranded in September 2025 and completed its…

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company. Founded in 2017 and headquartered in Chicago, Illinois, the company develops and commercializes clinical tests based on genetics …

Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company's lead small molecu…

Cardlytics, Inc. (NASDAQ: CDLX) operates a proprietary native bank advertising channel and purchase intelligence platform in the United States and the United Kingdom. The company partners with major financial institutions (FI partners), including JPMorgan Cha…

CareCloud, Inc. (Nasdaq: CCLD) is a leading provider of healthcare information technology, revenue cycle management (RCM), and generative AI-powered solutions designed for medical practices and health systems. The company's comprehensive suite of cloud-based …

CareTrust REIT, Inc. (NYSE: CTRE) is a self-administered, publicly traded real estate investment trust (REIT) specializing in the ownership, acquisition, development, and leasing of healthcare-related properties. The company's diverse portfolio consists prima…

CareDx, Inc. (Nasdaq: CDNA) is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. Headquartered in B…

Caribou Biosciences, Inc. (Nasdaq: CRBU) is a leading clinical-stage CRISPR genome-editing biopharmaceutical company co-founded by CRISPR pioneer and Nobel laureate Jennifer Doudna, Ph.D., and CEO Rachel Haurwitz, Ph.D.. The company is dedicated to developing…

Caris Life Sciences, Inc. (NASDAQ: CAI) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. The company is actively developing and commercializing innovative molecular profiling solutions to transform healthcare. …

Carlisle Companies Incorporated (NYSE: CSL) is a leading manufacturer and supplier of innovative building envelope products and solutions designed to enable greater energy efficiency in buildings. Following its strategic pivot to become a pure-play building p…

Carlsmed, Inc. (Nasdaq: CARL) is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. The company's core offering is the aprevo® Technology Platform, which utilizes outcomes-based artificial intelligence al…

The Carlyle Group Inc. (NASDAQ: CG) is one of the world's largest global alternative asset managers, with approximately $476.9 billion in total assets under management (AUM) and $336.8 billion in fee-earning AUM as of the end of 2025. Founded in 1987 and head…

Carlyle Secured Lending, Inc. (NASDAQ: CGBD) is a specialty finance company operating as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company (BDC) under the Investm…